SPONSOR
Prof. Wolfgang Janni
Total Trials
2
Recruiting
2
Phases
Phase 4
Conditions studied: Hormone Receptor-positive Metastatic Breast CancerHER2-negative Metastatic Breast CancerBreast Cancer
NCT05362760 Phase 4
Recruiting
Combination of Abemaciclib and Endocrine Therapy in Hormone Receptor Positive HER2 Negative Locally Advanced or Metastatic Breast Cancer With Focus on Digital Side Effect Management
Hormone Receptor-positive Metastatic Breast Cancer
NCT05658172
Recruiting
Standard Surveillance vs. Intensive Surveillance in Early Breast Cancer
Breast Cancer